SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cytokinetics, Incorporated ( CYTK)
An SI Board Since April 2004
Posts SubjectMarks Bans Symbol
405 30 0 CYTK
Emcee:  mopgcw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
55MPM :<i> five general partners wouldn’t go forward with the next fund, thamopgcw-5/13/2005
54I did read the article, but it seemed to point to a practical change in strategykeokalani'nui-5/12/2005
53True, think the spent some time licking their wounds...Did you see the MPM articmopgcw-5/12/2005
52Funny, haven't heard about the V-V public biotech investing side for a whilekeokalani'nui-5/12/2005
51Chuckle. or that means we should sell fast given his abysmal track record..mopgcw-5/12/2005
50Vulcan files for 8%, 13G. Way to go Paul, getting some good advice!keokalani'nui-5/12/2005
49GS: CYTK (IL/N): Q1 update, pipeline progressing 52-Week Range US$18-5 YTD Pricmopgcw-5/2/2005
48Very large volume traded today with little impact on the price ahead of the annomopgcw-4/27/2005
47Cytokinetics, Incorporated Reports First Quarter 2005 Financial Results Wednesdamopgcw-4/27/2005
46from the recent proxy: Name and Address of Beneficial Owner Number of Shares mopgcw-4/18/2005
45THANKS! (eom)mopgcw-4/9/2005
44Very worthwhile read.... cytokinetics.comrkrw-4/9/2005
43>>SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--April 5, 2005--Cytokinetictuck-4/5/2005
42FWIW: They have gotten hammered over the past few days. No news that I can seemopgcw-3/18/2005
41From Forbes: Cytokinetics Is At 'A High-Risk Stage' 03.15.05, 3:45 PM mopgcw-3/17/2005
40Cytokinetics Announces Selection of Heart Failure Drug Development Candidate Thumopgcw-3/7/2005
39GS: CYTK (IL/N):Pipeline progressing, increasing 2005 and 2006 loss estimates 5mopgcw-2/4/2005
38Cytokinetics, Incorporated Reports Fourth Quarter and Year End 2004 Financial Remopgcw-2/4/2005
37This burn is way North of what I was expecting. GSK and NIH are doing all the wkeokalani'nui-2/3/2005
36GS: CYTK (IL/N):Pipeline progressing, increasing 2004 & 2005 loss estimates mopgcw-1/6/2005
35>>SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Dec. 16, 2004-- Cytokinetituck-12/16/2004
34<i> I like CYTK, too, but as with ACAD, it's early, and the lock-up exmopgcw-12/8/2004
33ASCB data: >>SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Dec. 8, 2004--tuck-12/8/2004
32Message 20824002mopgcw-12/3/2004
31Pipeline: SB-715992 (kinesin spindle protein inhibitor) Continue Phase I 2-3rmopgcw-12/2/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News